Investment Strategy
Pursuing a dual-engine approach, pairing ecosystem leadership with focused internationalisation to preserve purity, compound value, and calibrate risk-return for disciplined, repeatable outcomes.
Strategy Architecture
Our architecture is built on two complementary engines: the Anchor Enterprise + Fund pathway, and the NewCo model—designed for ex-China rights and rapid international scale. Both serve the same mission: anchoring in Singapore, we convert premium Asian healthcare assets into globally relevant growth engines.
Under the Anchor Enterprise + Fund pathway, we co-invest deeply with industry-leading enterprises, deploying industrial funds to mobilise additional capital and acquiring or investing in high-quality healthcare companies. The result is a compounding cluster effect that fuses industry and finance, and further entrenches Singapore's strategic position.
Under the NewCo model, we establish overseas entities to hold ex-China rights to core assets, bring in international capital and globally minded management teams, and operate with the decision-making agility required to accelerate global expansion from a Singapore base.
The VCC umbrella supports both engines in parallel—running ring-fenced portfolios side by side, with fee structures, currency arrangements, and liquidity terms tailored at the sub-fund level. Investors can select the engine best aligned to their objectives without sacrificing governance discipline or strategic focus.
Why We Are Different
What sets us apart is not our choice of asset class, but the depth and manner of our engagement with the market:
-
Competition has shifted to the value chain. By anchoring to industry-leading partners, we orchestrate upstream and downstream capabilities to unlock systemic industrial advantage—rather than make isolated bets on individual companies.
-
The NewCo pathway concentrates funding on well-defined pipelines, builds a global IP footprint, and creates multiple optionality—staged financing, M&A consolidation, and capital-markets exits—while leveraging Singapore as the strategic bridgehead.
-
Because every strategy sits inside its own sub-fund, we preserve strategic purity while retaining the ability to scale or add vehicles as market windows open—giving investors flexible deployment and reallocation channels, and the capacity to optimise in real time.
In short, we are not merely a capital allocator. We are a strategic operating partner for companies anchoring in Singapore, localising their operations, and expanding across ASEAN.
